- France
- /
- Electronic Equipment and Components
- /
- ENXTPA:LBIRD
€12.50: That's What Analysts Think Lumibird SA (EPA:LBIRD) Is Worth After Its Latest Results
There's been a notable change in appetite for Lumibird SA (EPA:LBIRD) shares in the week since its interim report, with the stock down 12% to €8.50. Lumibird reported in line with analyst predictions, delivering revenues of €98m and statutory earnings per share of €0.32, suggesting the business is executing well and in line with its plan. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Lumibird after the latest results.
See our latest analysis for Lumibird
Taking into account the latest results, the most recent consensus for Lumibird from two analysts is for revenues of €212.3m in 2024. If met, it would imply an okay 2.4% increase on its revenue over the past 12 months. Before this earnings report, the analysts had been forecasting revenues of €218.9m and earnings per share (EPS) of €0.60 in 2024. So we can see that while the consensus made a minor downgrade to revenue estimates, it no longer provides an earnings per share estimate. This suggests that the market is now more focused on revenue after the latest result.
Intriguingly,the analysts have cut their price target 23% to €12.50 showing a clear decline in sentiment around Lumibird's valuation.
Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that Lumibird's revenue growth is expected to slow, with the forecast 4.8% annualised growth rate until the end of 2024 being well below the historical 15% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 24% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Lumibird.
The Bottom Line
The most important thing to take away is that the analysts downgraded their revenue estimates for next year. Unfortunately, they also downgraded their revenue estimates, and our data indicates it is expected to perform worse than the wider industry. Furthermore, the analysts also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.
At least one of Lumibird's two analysts has provided estimates out to 2026, which can be seen for free on our platform here.
It is also worth noting that we have found 3 warning signs for Lumibird (1 doesn't sit too well with us!) that you need to take into consideration.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTPA:LBIRD
Lumibird
Designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide.
Reasonable growth potential with adequate balance sheet.